Alzheimer's Disease

Showing NaN - NaN of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +132 more
Nov 19, 2019

Alzheimer's Disease Trial in United States (BPN14770, Placebo)

Unknown status
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +40 more
Oct 30, 2019

Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)

Terminated
  • Alzheimer's Disease
  • Group 1 ELND005
  • Group 2 ELND005
  • Birmingham, Alabama
  • +45 more
Oct 17, 2019

Alzheimer's Disease Trial in Canada, United States (ELND005 (scyllo-inositol))

Completed
  • Alzheimer's Disease
  • ELND005 (scyllo-inositol)
  • Phoenix, Arizona
  • +37 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (ELND005, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +69 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Alzheimer's Disease Trial in Delray Beach, Miami, Charlotte (T3D-959)

Completed
  • Alzheimer's Disease
  • Delray Beach, Florida
  • +2 more
Jul 26, 2018

Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)

Completed
  • Alzheimer's Disease
  • Bryostatin 1
  • Placebo
  • Phoenix, Arizona
  • +28 more
Jun 6, 2018

Alzheimer's Disease Trial in Worldwide (LY2886721, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +33 more
May 16, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +161 more
Jan 23, 2018

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +3 more
  • Litchfield Park, Arizona
  • +248 more
Oct 23, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)

Terminated
  • Alzheimer's Disease
  • Rosiglitazone XR
  • Litchfield Park, Arizona
  • +271 more
Oct 11, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +2 more
  • Sun City, Arizona
  • +193 more
Aug 3, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017

Alzheimer's Disease Trial in Worldwide (RO4602522, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +141 more
May 25, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +137 more
Apr 13, 2017

Alzheimer's Disease Trial in Worldwide (PF-05212377 (SAM-760), Placebo)

Terminated
  • Alzheimer's Disease
  • PF-05212377 (SAM-760)
  • Placebo
  • Costa Mesa, California
  • +59 more
Jan 30, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, RO5313534)

Completed
  • Alzheimer's Disease
  • Orange, California
  • +66 more
Nov 1, 2016